Literature for CLIK148 (C01.001 inhibitor)

(Topics flags: S Structure, K Knockout, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2010
1. Yamada,A., Ishimaru,N., Arakaki,R., Katunuma,N. and Hayashi,Y.
   Cathepsin L inhibition prevents murine autoimmune diabetes via suppression of CD8(+) T cell activity
   PLoS ONE5, e12894-e12894. PubMed  Europe PubMed DOI  I
2009
2. Beinfeld,M.C., Funkelstein,L., Foulon,T., Cadel,S., Kitagawa,K., Toneff,T., Reinheckel,T., Peters,C. and Hook,V.
   Cathepsin L plays a major role in cholecystokinin production in mouse brain cortex and in pituitary AtT-20 cells: protease gene knockout and inhibitor studies
   Peptides30, 1882-1891. PubMed  Europe PubMed DOI  K  I
3. Yoshii,H., Kamiyama,H., Minematsu,K., Goto,K., Mizota,T., Oishi,K., Katunuma,N., Yamamoto,N. and Kubo,Y.
   Cathepsin L is required for ecotropic murine leukemia virus infection in NIH3T3 cells
   Virology394, 227-234. PubMed  Europe PubMed DOI  I
2008
4. Beavers,M.P., Myers,M.C., Shah,P.P., Purvis,J.E., Diamond,S.L., Cooperman,B.S., Huryn,D.M. and Smith,A.B., III
   Molecular docking of cathepsin L inhibitors in the binding site of papain
   J Chem Inf Model48, 1464-1472. PubMed  Europe PubMed DOI  S  I
5. Shah,P.P., Myers,M.C., Beavers,M.P., Purvis,J.E., Jing,H., Grieser,H.J., Sharlow,E.R., Napper,A.D., Huryn,D.M., Cooperman,B.S., Smith,A.B., III and Diamond,S.L.
   Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L
   Mol Pharmacol74, 34-41. PubMed  Europe PubMed DOI  S  I
2004
6. Onishi,K., Li,Y., Ishii,K., Hisaeda,H., Tang,L., Duan,X., Dainichi,T., Maekawa,Y., Katunuma,N. and Himeno,K.
   Cathepsin L is crucial for a Th1-type immune response during Leishmania major infection
   Microbes Infect6, 468-474. PubMed  Europe PubMed DOI  I
1999
7. [YEAR:10-9-1999]Katunuma,N., Murata,E., Kakegawa,H., Matsui,A., Tsuzuki,H., Tsuge,H., Turk,D., Turk,V., Fukushima,M., Tada,Y. and Asao,T.
   Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo
   FEBS Lett458, 6-10. PubMed  Europe PubMed DOI  I
8. [YEAR:20-12-1999]Tsuge,H., Nishimura,T., Tada,Y., Asao,T., Turk,D., Turk,V. and Katunuma,N.
   Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex
   Biochem Biophys Res Commun266, 411-416. PubMed  Europe PubMed DOI  S  I